Glioma
📧 Sign up to get email alerts when something new happens for Glioma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-10-19Clinical Trial Update: iMRI Guided Resection in Cerebral Glioma Surgery [Phase 3]
Phase 3 clinical trial evaluating iMRI-guided resection in cerebral glioma surgery has completed.
-
CLINICAL_TRIALS trial_result · 2021-08-02Clinical Trial Update: Study Evaluating the Efficacy and Safety of Selinexor (KPT-330) in Participants With Recurrent Gliomas [Phase 2]
Phase 2 trial evaluating selinexor (KPT-330) in recurrent gliomas was terminated; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-07-15Clinical Trial Update: Combination Adenovirus + Pembrolizumab to Trigger Immune Virus Effects [Phase 2]
Phase 2 trial evaluating combination of an oncolytic adenovirus with pembrolizumab for brain cancers has completed.
-
CLINICAL_TRIALS trial_result · 2021-05-13Clinical Trial Update: GP96 Heat Shock Protein-Peptide Complex Vaccine in Treating Patients With Recurrent or Progressive Glioma [Phase 1, Phase 2]
Phase 1/2 trial of GP96 heat shock protein-peptide complex vaccine for recurrent or progressive glioma completed; results posted.
-
CLINICAL_TRIALS trial_result · 2021-04-15Clinical Trial Update: A Study of High-Dose Chemoradiation Using Biologically-Based Target Volume Definition in Patients With Glioblastoma [Phase 2]
Phase 2 trial investigating high-dose chemoradiation with biologically-based target volume definition in glioblastoma.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-03-18Clinical Trial Update: Disulfiram in Recurrent Glioblastoma [Phase 2, Phase 3]
Clinical trial update for disulfiram in recurrent glioblastoma, reporting Phase 2 and Phase 3 results; study status is completed.
-
CLINICAL_TRIALS trial_result · 2021-03-15Clinical Trial Update: IDH1 Peptide Vaccine for Recurrent Grade II Glioma [Phase 1]
Phase 1 trial update of an IDH1 peptide vaccine for recurrent grade II glioma has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-02-23Clinical Trial Update: Study of Orally Administered Enasidenib (AG-221) in Adults With Advanced Solid Tumors, Including Glioma, or Angioimmunoblastic T-cell Lymphoma, With an IDH2 Mutation [Phase 1, Phase 2]
Clinical trial update for enasidenib (AG-221) in adults with advanced solid tumors, glioma, or angioimmunoblastic T-cell lymphoma harboring …
-
CLINICAL_TRIALS trial_result · 2021-02-04Clinical Trial Update: Autologous CAR-T/TCR-T Cell Immunotherapy for Solid Malignancies [Phase 1, Phase 2]
Clinical trial update on autologous CAR-T/TCR-T cell therapy for solid malignancies across Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2021-01-12Clinical Trial Update: Feasibility and Clinically Application of Magnetic Resonance Fingerprinting [NA]
Clinical trial investigating magnetic resonance fingerprinting in Neurofibromatosis type 1 with brain tumors was terminated; results posted …
-
CLINICAL_TRIALS trial_result · 2020-12-17Clinical Trial Update: Image-Guided Stereotactic Biopsy of High Grade Gliomas [NA]
Clinical trial update on image-guided stereotactic biopsy for high-grade gliomas; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-12-16Clinical Trial Update: Anlotinib to Malignant Brainstem Glioma [Phase 2]
Phase 2 trial update evaluating anlotinib in malignant brain stem glioma and glioma.
-
CLINICAL_TRIALS trial_result · 2020-11-17Clinical Trial Update: Optune® Plus Bevacizumab in Bevacizumab-Refractory Recurrent Glioblastoma [Phase 2]
Phase 2 trial investigating Optune plus Bevacizumab in bevacizumab-refractory recurrent glioblastoma; study terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2020-10-12Clinical Trial Update: Hypofractionated IMRT With Temozolomide for HGG [NA]
Clinical trial evaluating hypofractionated IMRT with temozolomide for glioma has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2020-09-09Clinical Trial Update: Study of DC Vaccination Against Glioblastoma [Phase 2]
Phase 2 clinical trial update on dendritic cell vaccination for glioma/glioblastoma; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2020-06-09Clinical Trial Update: Clinical Study of an Dendritic and Glioma Cells Fusion Vaccine With IL-12 for Treatment-naïve GBM Patients. [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating a dendritic cell and glioma cell fusion vaccine with IL-12 for treatment-naïve glioblastoma/glioma pat…
-
CLINICAL_TRIALS trial_result · 2020-05-12Clinical Trial Update: Bevacizumab and Carmustine in Treating Patients With Relapsed or Progressive High-Grade Glioma [Phase 2]
Phase 2 clinical trial evaluating bevacizumab with carmustine in relapsed or progressive high-grade glioma has completed with results posted…
-
CLINICAL_TRIALS trial_result · 2020-04-24Clinical Trial Update: Study of Platelet Derived Growth Factor Receptor (PDGFR) in Recurrent Malignant Gliomas [Phase 2]
Phase 2 trial update on targeting PDGFR in recurrent malignant gliomas has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2020-02-25Clinical Trial Update: ANG1005 in Patients With Recurrent High-Grade Glioma [Phase 2]
Phase 2 clinical trial update for ANG1005 in patients with recurrent high-grade glioma, including glioblastoma and other gliomas; status com…
-
CLINICAL_TRIALS trial_result · 2020-02-05Clinical Trial Update: Everolimus for Children With NF1 Chemotherapy-Refractory Radiographic Progressive Low Grade Gliomas [Phase 2]
Phase 2 clinical trial update on everolimus for children with NF1-associated chemotherapy-refractory radiographic progressive low-grade glio…
-
CLINICAL_TRIALS trial_result · 2020-01-09Clinical Trial Update: Metformin And Chloroquine in IDH1/2-mutated Solid Tumors [Phase 1, Phase 2]
Phase 1/2 trial investigating metformin and chloroquine in IDH1/2-mutated solid tumors has completed.
-
CLINICAL_TRIALS trial_result · 2019-12-11Clinical Trial Update: Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies [Phase 1, Phase 2]
Phase 1/2 clinical trial update for autologous CAR-T/TCR-T cell immunotherapy targeting multiple malignancies; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2019-12-04Clinical Trial Update: A Phase 2 Study of BGJ398 in Patients With Recurrent GBM [Phase 2]
A Phase 2 study of BGJ398 in patients with recurrent glioblastoma and related glioma subtypes has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2019-11-12Clinical Trial Update: Hyperfractionated RT With BCNU Versus Conventional RT With BCNU for Supratentorial Malignant Glioma [Phase 3]
Phase 3 trial comparing hyperfractionated radiotherapy with BCNU to conventional radiotherapy with BCNU in supratentorial malignant glioma.
-
CLINICAL_TRIALS trial_result · 2019-07-23Clinical Trial Update: TMZ Plus Apatinib in Newly Diagnosed High-grade Glioma：RCT [Phase 2]
Phase 2 randomized trial investigating temozolomide plus apatinib in newly diagnosed high-grade glioma.